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ABSTRACT
Objectives: To engage young people, parent carers
and clinicians in a systematic process to identify and
prioritise research questions regarding ways to improve
the health and well-being of children and young people
with neurodisability.
Design: British Academy of Childhood Disability
(BACD)-James Lind Alliance research priority setting
partnership bringing together patients, carers and
clinicians as equal stakeholders.
Setting: UK health service and community.
Methods: The BACD Strategic Research Group formed
the partnership. A Steering Group was established;
charity and professional partner organisations were
recruited. Suggestions were gathered in an open
survey and from research recommendations for
statutory guidance. Items were aggregated to formulate
indicative research questions and verified as
uncertainties from research evidence. An interim survey
was used to rank the questions to shortlist topics.
A mixed group of stakeholders discussed the top 25
questions at the final priority setting workshop
agreeing a final rank order and the top 10 research
priorities.
Participants: Partner organisations were 13 charities
and 8 professional societies. 369 people submitted
suggestions (40% non-clinicians). 76 people
participated in the interim prioritisation (26 parents,
1 young person, 10 charity representatives,
39 clinicians); 22 took part in the final workshop
(3 young people, 7 parents, 3 charity representatives,
9 professionals).
Results: The top three research priorities related to
(1) establishing the optimal frequency and intensity
(dose) for mainstream therapies, (2) means for
selecting and encouraging use of communication
strategies and (3) ways to improve children’s attitudes
towards disability. The top 10 included evaluating
interventions to promote mobility, self-efficacy, mental
health, continence, physical fitness, educational
inclusion and reduce impacts of sleep disturbance.
Conclusions: The methodology provided a systematic
and transparent process to identify research priorities
that included stakeholders that have typically not
contributed to setting the research agenda. The top 10
and other topics identified provide a resource for
researchers and agencies that fund research
BACKGROUND
Patients, carers and members of the public
are encouraged to become involved as part-
ners in research.1 2 Patient and public
Strengths and limitations of this study
▪ Systematic and transparent process that included
stakeholders that have often not had a say in
setting the research agenda;
▪ Young people, parent carers and clinicians
agreed on the top 10 priority topics;
▪ Non-categorical approach to neurodisability pro-
duced research questions that need to be
answered for the broad population of children
and young people;
▪ Non-categorical approach will exclude specific
issues for children and young people with a par-
ticular diagnosis or syndrome;
▪ The scope focused on interventions and process
cannot identify all potential research questions;
therefore, some important topics were not
included;
▪ Methodological challenges included engaging
young people in the survey and the many issues
raised that could not be framed as research
questions.
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involvement is mandatory in the UK for health research
funded through public taxation. Similar strategies are
being adopted for instance in Canada, USA and
Australia, using analogous terms. Patient and public
involvement in health research is philosophically
correct, believed to confer pragmatic beneﬁts that
improve the utility and conduct of research, and has
positive impacts on the people involved.3–5
A key issue in applied health research is deciding
which research questions are addressed and investigated.
In the past, researchers have generally decided the
research topics6 and, unintentionally, have tended to
pursue their perceived priorities which may not be the
same as those of patients and carers.7 At worst, this leads
to research ﬁndings that do not inform real-world deci-
sions and are wasteful of scarce resources.8 Hence,
increasingly, there is a role for patients, carers and non-
research active clinicians in shaping research
agendas.9 10 To fulﬁl this aspiration detailed methodolo-
gies require to be developed; these methods require
advertising and explaining the opportunities to be
involved, moving from issues of interest to framing tract-
able research questions and ﬁnding ways to prioritise
topics identiﬁed by taking account of the various com-
plexities and competing preferences.
The James Lind Alliance ( JLA) is a non-proﬁt making
initiative established in 2004 and now coordinated by
the National Institute for Health Research (NIHR) to
support patients, carers and clinicians working together
to agree on the most important treatment uncertainties
for particular health conditions.11 The JLA deﬁnition of
a treatment uncertainty is that no up-to-date, reliable sys-
tematic reviews exist or up-to-date systematic reviews
conﬁrm equipoise. The JLA methodology aims to make
patients and carers as empowered as clinicians in all
stages in the process. The JLA process is about hearing
the voices of patients, carers and clinicians who, unlike
researchers and industry, do not normally have an
opportunity to inﬂuence the research agenda. Without
their voices, areas of potentially important research that
could inform decisions may be neglected. The JLA exists
to redress this imbalance. The role of researchers in
taking issues forward is well recognised and the JLA is
keen to work with researchers who have an interest in
the shared priorities of patients, carers and clinicians to
make use of the results of the priority setting process.
The JLA methods are in many ways deﬁned and trans-
parent, although these are constantly developing; they
encourage ﬂexibility to meet the needs of particular
contexts and groups.
Neurodisability is an umbrella term for conditions asso-
ciated with impairment of the nervous system, such as
cerebral palsy, autism, epilepsy and an array of less
common syndromes (box 1).12 Research activity in neuro-
disability has been observed to be associated with severity
and prevalence of particular conditions, although there
are exceptions.13 Recent growth in research was noted
not to be proportionate to the severity or numbers of
comorbidities, and greater for autism and attention
deﬁcit hyperactivity disorder (ADHD).13 The British
Academy of Childhood Disability (BACD) is a UK organ-
isation for professionals working with children and young
people with all forms of disability (http://www.bacdis.org.
uk/about). BACD is committed to collaborating closely
with families of disabled children and includes parent
carers in its management structure. One of the key aims
of the Strategic Research Group (SRG) of BACD is to
encourage and assist people in the ﬁeld, including fam-
ilies and clinicians, to identify research priorities.14 The
BACD Executive Committee and SRG established a
working group for a JLA Research Priority Setting
Partnership (PSP) focusing on neurodisability in 2012
and provided funding. The initiative took a non-
categorical approach to identify treatment uncertainties
that were common across neurodisability; however, we
recognised that some issues that might arise would be
speciﬁc to particular conditions.
The BACD Executive and SRG set the scope as “any
ways to improve the health and/or well-being of chil-
dren and young people with neurodisability where there
is uncertainty of the effectiveness of an intervention,
therapy or procedure”. Each term in the scope was
deﬁned (see online supplementary ﬁle 1); interventions
were broadly any environmental factor in the
International Classiﬁcation of Functioning Disability and
Health (ICF).15 The SRG advised on methods to
increase community participation but then had no
further role to receive progress reports.
The objectives of the BACD-JLA Childhood Disability
Research PSP were to: (1) enable patients, parent carers
and clinicians to identify treatment uncertainties, (2)
agree by consensus on a prioritised list, (3) publicise the
results and processes and (4) promote the priorities to
researchers and funding agencies.
METHODS
The methodology followed guidance recommended in
the JLA Guidebook.16
Steering Group
A Steering Group was convened with patient, carer and
clinician representatives. Two members were from the
Box 1 Definition of neurodisability
What is ‘neurodisability’?
For the purposes of this project: “Neurodisability describes a
group of congenital or acquired long-term conditions that are
attributed to impairment of the brain and or neuromuscular
system and create functional limitations. A specific diagnosis may
or may not be identified. Conditions may vary over time, occur
alone or in combination, and include a broad range of severity
and complexity. The impact may include disturbances of move-
ment, cognition, hearing and vision, communication, emotion and
behaviour”.
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National Network of Parent Carer Forums (NNPCF,
http://www.nnpcf.org.uk), a young adult and charity
representative from the Council for Disabled Children, a
paediatrician, a researcher (and former allied health
professional), the editor of the UK Database of
Uncertainties about the Effects of Treatments (UK
DUETs), and was chaired by a JLA advisor.
The group met on seven occasions at key stages in the
project and discussed matters arising in between by tele-
conference calls. Travel expenses were reimbursed and
the time of non-salaried members was acknowledged at
£75 per meeting. No formal training was provided; the
JLA advisor supported the group throughout to under-
stand steps and processes, for example, framing research
questions.
Partner organisations and societies
Disability and condition-speciﬁc charitable organisations
supporting families of children and young people with
neurodisability, and professional societies and special
interest groups were made aware of the project and
invited to become partners. Members of the Steering
Group approached representatives of some organisations
through personal contacts; other organisations were
invited to take part through their generic email address
and some charities approached the PSP themselves.
Agencies commissioning childhood disability research
were also made aware of the project. Partners were listed
on the PSP website (http://www.bacdis.org.uk/
research/psp.htm).
Identifying uncertainties
Uncertainties were gathered from families and clinicians
through a survey and from research recommendations
in the UK and WHO guidance documents.
The Steering Group reviewed examples of questions
and formats for administering the survey used in JLA
PSPs for other conditions. There was debate on an open
question approach versus a more structured format
asking for speciﬁcation of particular patients, interven-
tion, comparator and outcome (PICO). On balance, an
open approach was preferred to enable people to
express themselves freely; additional questions were
included to identify key characteristics of people partici-
pating in the survey, and an option to provide an email
or postal address to be kept informed about the project.
An online survey was set up as the predominant way to
gather uncertainties; the format was piloted and reﬁned
following feedback. A link to the survey was then for-
warded to partner organisations and societies, and adver-
tised by them using various media, such as newsletters;
an invitation was forwarded to the contact person at
child development teams on the BACD database and
the link was also available on the BACD PSP website.
Printed copies of the questionnaire were made available
at several events for parent carers and young people
with freepost return envelope; these data were then
entered into the online survey.
The Steering Group monitored responses to the
survey and under-represented groups were more purpos-
ively targeted while the survey was live. For example,
work was undertaken by the NNPCF to promote the
survey more actively to parent carers by making clearer
the beneﬁts of taking part and the Council for Disabled
Children provided opportunities to include the views of
children and young people at their events.
Research recommendations were extracted from rele-
vant guidance from the National Institute for Health
and Care Excellence (NICE), Scottish Intercollegiate
Guidance Network (SIGN), and by scanning relevant
topics in the Cochrane Library (by JC in consultation
with DS). Research recommendations from the World
Report on Disability17 were also examined (by CM).
Organising uncertainties
Survey suggestions and person identiﬁcation data were
downloaded from the online database. The Steering
Group reviewed a subset of the submissions. Each was
discussed in turn to decide whether it was within the
scope of the project and then whether a PICO struc-
tured research question could be formulated.
Two authors reviewed all submissions and discussed
the topics raised (CM/AJ). A coding approach was
developed to identify issues suggested as: (1) in/out of
scope, (2) symptom/impairment, (3) condition, and (4)
intervention. Two people (CM/AJ) coded 50% submis-
sions independently, compared results and discussed
reasons for disagreements. Once a consistent approach
was agreed, CM coded all data. Three lists of survey sug-
gestions were presented at the subsequent Steering
Group meeting, that is, those that were in scope, out of
scope or borderline; more discussions focused on bor-
derline cases and ﬁnal decisions were agreed.
Refining research questions from uncertainties
Aggregating survey suggestions by type of impairment or
diagnosis, and by intervention enabled broadly similar
suggestions to be grouped together. A research question
was then drafted for each issue. The Steering Group
reviewed each research question and considered
whether the wording should be revised.
Checking uncertainties
The veracity of whether research questions were uncertain
was checked by reference to published systematic reviews.
The databases searched were the Cochrane Library
(http://www.thecochranelibrary.com/view/0/index.html),
NHS Centre for Reviews and Dissemination (http://www.
crd.york.ac.uk/CRDWeb) and Prospero (http://www.crd.
york.ac.uk/PROSPERO). The WHO International Clinical
Trials Search Portal (apps.who.int/trialsearch) was
searched to identify any ongoing trials.
One person (CM) conducted the search and a second
person (DS) audited these data by repeating searches to
propose adding or removing of any references.
Uncertainty was conﬁrmed if there was: (1) no review,
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(2) one or more recent, relevant and reliable review(s)
indicated an equivocal answer or (3) an out-of-date
review (over 3 years old) indicated an equivocal answer.
We also consulted several topic experts in various ﬁelds
to help make decisions.
Data were managed in a spreadsheet and prepared as
per the speciﬁcation for entry into UK DUETs (by AS
and CM).16 Research recommendations from NICE,
SIGN and the World Report on Disability were inte-
grated. The data set was checked by the UK DUETs’
database manager (MF), and edited accordingly.
Interim prioritisation
The Steering Group approved a ‘long list’ of research
questions. The long list and a questionnaire to indicate
rankings of the top 10 preferences for priorities was sent
to partner organisations, and people who participated in
the original survey and had provided a contact email or
postal address. Returns in the interim prioritisation
survey were categorised into one of the three types of
stakeholders (young person or parent/carer; organisa-
tions supporting families; clinicians and professional
societies). The rankings were entered into a spreadsheet
for analysis of the more popular prioritised questions
within each stakeholder group. Each submission was
scored such that a question with rank 1 was given 10
points, rank 2 had 9 points and rank points went down
such that rank 10 was given 1 point. Points for each
group were tallied separately; so each of the three
groups ended up with its own total for each of the 53
questions. Within each group, the totals for each ques-
tion were put into rank order and given a new score,
from most to least popular. Where a question had not
been ranked at all, it was given 0 points. Questions that
had the same total were given an average score between
them.
The Steering Group considered the ratings and
agreed on a short list of 25 questions based on an aggre-
gated score across stakeholder groups; these questions
were taken forward for consideration at the ﬁnal priority
setting workshop.
Priority setting workshop
A face-to-face stakeholder meeting was convened to
discuss, agree and rank a shared view of research prior-
ities. The Steering Group invited 24 participants and
sought to balance the different types of stakeholders.
Partner organisations and societies were invited to nom-
inate representatives; Council for Disabled Children
(CDC) invited young people with neurodisability and
NNPCF invited parent carers. A broad range of clini-
cians were invited, including occupational therapists,
physiotherapists, speech and language therapists, nurses,
paediatricians, teachers, surgeons, clinical psychologists
and psychiatrists. Non-salaried participants were offered
an acknowledgement for their time (£75); travel
expenses were reimbursed.
The workshop agenda was structured based on JLA
recommended guidance.16 The approach is a variation
of nominal group methodology that seeks to ensure all
stakeholders are able to voice their views equally.18
Participants were provided with the 25 questions in
advance and asked to rank them. Three independent
facilitators managed all discussions. Initially, participants
worked in three mixed small groups; then the compos-
ition of the groups was changed; and ﬁnally, all the parti-
cipants worked collectively. The shortlisted questions
were presented on one side of large cards; on the other
side were the ranked positions from each stakeholder
group from the interim prioritisation. Facilitators used
this information to encourage debate after participants
discussed their personal preferences. At each stage, the
cards were arranged and rearranged in order of import-
ance based on group preferences. If broad agreement
was not apparent then a vote was used. The ﬁnal rank
ordering represented the priorities set.
Dissemination
The Steering Group developed a dissemination strategy
in advance of the ﬁnal priority setting workshop; the
plan included using a variety of media to reach different
audiences to share the priorities with research funding
agencies, and also our experiences and lessons learnt.
Ethics statement
The JLA methodology has public and patient involve-
ment in research. The people who take part in the
survey and priority setting stages of the work are not
research participants. Thus, there is no requirement for
ethics approval.
RESULTS
The PSP engaged a variety of stakeholder organisations
and societies as partners; however, this early stage of the
process took longer than anticipated. It took more to
engage professional societies rather than charities,
which readily joined the partnership. Partners included
13 charities and 8 professional societies or special inter-
est groups.
There were 475 registrants to the survey, of which 369
people submitted 809 suggestions of uncertainties (40%
were non-clinicians); 106 people registered but made no
suggestions, of which 42 provided an email address to be
kept informed. There was considerable disagreement
when two researchers coded the suggestions independ-
ently (40%), but following a discussion a consistent
approach was agreed on. After removing 453 out-of-scope
suggestions, 356 items remained. Reasons for items being
considered out-of-scope were that they pertained to cure
or screening, no intervention was speciﬁed and no inter-
vention could be inferred. The Steering Group reviewed
and agreed on including/excluding those items coded
as ‘maybe’ and ‘out-of-scope’. A third of the ﬁnal
in-scope suggestions were from non-clinicians (table 1);
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approximately, half of the out-of-scope suggestions were
from non-clinicians. After coding, 71 potential research
questions were identiﬁed. The Steering Group discussed
and reduced this list to 57 items by merging similar
issues. All were conﬁrmed as uncertainties from research
ﬁndings based on the JLA criteria with reference to sys-
tematic reviews where available. Topic experts consulted,
for example, regarding orthopaedic management or
management of sleep disturbance, conﬁrmed equipoise
based on high-quality research evidence, even if their per-
sonal views were less uncertain.
Three questions focused on the timing, intensity and
duration of physical, occupational or speech and
language therapies; these were merged as one item.
Fifty-three candidate questions were included in the
interim prioritisation survey (see online supplementary
ﬁle 2). Responses were received from 76 participants: 26
parents and 1 young person, 10 representatives from
eight charities, 39 clinicians. Scores were added across
the three groups resulting in a ranked list and 25 ques-
tions were taken forward to the ﬁnal prioritisation
workshop.
Participants in the ﬁnal prioritisation meeting came
from various regions of England. There were 3 young
adults with neurodisability, 7 parent carers, 3 represen-
tatives from generic child disability charities, a disability
Table 1 Participants in the survey to identify uncertainties and source of suggestions classified as in-scope
Registered for
survey (n=475)
Submitted at
least one
suggestion
(n=369)
Source of
suggestions
within scope
(n=356)
N Per cent N Per cent N Per cent
Stakeholder
Paediatrician 44 9.3 40 10.8 49 13.8
Paediatric neurologist 7 1.5 7 1.9 3 0.8
Surgeon 12 2.5 10 2.7 12 3.4
Nurse 12 2.5 10 2.7 11 3.1
Speech and language therapist 29 6.1 19 5.1 12 3.4
Physiotherapist 61 12.8 55 14.9 72 20.2
Occupational therapist 39 8.2 35 9.5 49 13.8
Orthotist/prosthetist 4 0.8 4 1.1 6 1.7
Psychiatrist 6 1.3 5 1.4 8 2.2
Psychologist 1 0.2 0 0 0 0
Dentist 1 0.2 1 0.3 1 0.3
Teacher 2 0.4 2 0.5 1 0.3
Academic/researcher 2 0.4 2 0.5 1 0.3
Specialist health visitor 1 0.2 1 0.3 1 0.3
Audiologist 1 0.2 0 0 0 0
Orthotist 1 0.2 1 0.3 0 0
Administrator or manager 1 0.2 1 0.3 0 0
GP 2 0.4 6 1.6 1 0.3
Health professional (not further specified) 11 2.3 1 0.3 3 0.8
Parent and health professional 5 1.1 2 0.5 10 2.8
Part of an organisation supporting disabled people 29 6.1 2 0.5 8 2.2
Parent, carer, relative of someone with neurodisability 183 38.5 138 37.4 103 28.9
Young person aged 24 or under with neurodisability 11 2.3 6 1.6 3 0.8
Person aged 25 or over with a neurodisability 8 1.7 1 0.3 0 0
Missing data 2 0.4 2 0.5 2 0.6
Total 475 100 369 100 356 100
Region
London 45 9.5 30 8.1 15 4.2
England (not London) 150 31.6 122 33.1 92 25.8
Northern Ireland 5 1.1 2 0.5 2 0.6
Scotland 16 3.4 10 2.7 7 2.0
Wales 10 2.1 6 1.6 4 1.1
Outside UK 3 0.6 2 0.5 2 0.6
Missing data 246 51.8 197 53.4 234 65.7
Total 475 100 369 100 356 100
The ‘registered’ and ‘submitted at least one suggestion’ columns represent individuals; the ‘source of suggestions within scope’ column
includes some items where an individual may have made more than one suggestion.
GP, general practitioner.
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advisor in education and 8 health professionals
(paediatrician, speech and language therapist, 3 phy-
siotherapists, occupational therapist, nurse, ortho-
paedic surgeon); two other professionals sent apologies
on the day. Three representatives from NIHR observed
the meeting.
Rationales for prioritisation we observed in the discus-
sions included the number of children likely to beneﬁt
and the intensity of the impact of the symptom, broader
consequences for families, likelihood of research
informing clinical, policy or family decisions. The rank-
ings from the ﬁrst small groups were compared and
aggregated; further discussions in the same and differ-
ent small groups led to modiﬁcations to the ordering.
Finally, all participants discussed the 25 research topics
together in a plenary session, and a rank order and top
10 were agreed (table 2, box 2). Minor modiﬁcations
suggested by participants at the workshop were made to
some questions. A summary of the process and numbers
at each stage is illustrated in ﬁgure 1.
The top priority issue across all stakeholders in the
interim survey and in the ﬁnal workshop with small
groups relates to the timing and intensity of physical,
occupational, and speech and language therapy. The
question asks whether therapies are more effective if
implemented when children are younger and whether
there is an optimum ‘dose’ (intensity, frequency, dur-
ation) for the therapy to be effective. The second prior-
ity relates to the appropriate selection of augmentative
and alternative communication strategies; this priority
also includes evaluating ways to encourage people to use
the strategies in everyday life. The third priority is for
research to evaluate ‘child-focused’ interventions to
promote positive attitudes towards disability among chil-
dren and young people in the general population. The
‘top 10’ priorities also included a call for research to
evaluate various treatments and therapies to promote
mobility, self-efﬁcacy, mental health, continence, physical
ﬁtness, educational inclusion, and reduce the impacts
on the child and family from sleep disturbance.
In terms of dissemination, this paper is an academic
output describing the process; a plain language
summary will be made available and separate documents
are being used to publicise the ﬁndings (see online sup-
plementary ﬁles 2 and 3). Engaging NIHR staff in the
process has raised the proﬁle of the PSP and priority
research topics. The top 10, ranked 25,, and all 53 topics
are being sent to relevant NIHR programmes, UK
Research Councils and research charities identiﬁed by
the Steering Group, with attention drawn to speciﬁc
topics within the scope of each agency (eg, technology
appraisal, public health and education).
DISCUSSION
The BACD-JLA Childhood Disability Research PSP
brought together patients, carers and clinicians to iden-
tify and rank research questions. The longer list of
53 questions and top 10 ‘shared priorities’ provide a
resource to inform commissioning decisions in govern-
ment and charitable agencies that fund research. The
uncertainties raised and prioritised are the outcome of a
systematic and transparent process that includes stake-
holders that have often not had a say in setting the
research agenda. However, the process cannot feasibly
identify all potential research questions from stake-
holders and researchers did not contribute their ideas
to the survey; therefore, some other topics were not
identiﬁed and considered. Thus, our results should be
considered ‘a top 10’ shared priorities based on those
who engaged and participated in the process, rather
than ‘the deﬁnitive top 10’. We suspect that a different
sample of stakeholder participants might not necessarily
produce precisely the same result. The JLA advised that
the inclusion of issues that researchers do not necessar-
ily consider as research priorities is actually a mark of
success of the process. We received guidance from the
JLA Advisory Group that prioritisation should not be
inﬂuenced by methodological challenges and the feasi-
bility of addressing the research questions. While
researchers were less represented in the partnership,
given the JLA focus on giving patients, carers and clini-
cians a say in setting the research agenda, the engage-
ment of researchers who are keen to undertake research
to address their priorities is essential. We hope research-
ers and funding agencies will consider seriously these
priority topics to inﬂuence directions for future evalu-
ative research in this area.
Many of the research questions are necessarily broad
in order to capture the wide range of issues raised in the
survey and research recommendations, and for reﬂect-
ing the focus on neurodisability. Hence, these ‘indicative
questions’ represent topics for research. The process
shows how much there is in common in the questions
that need to be answered for children and young people
with neurodisability. This reﬂects experience on the
ground from the many thousands of families that belong
to pan-disability Parent Carer Forums that are part of
the NNPCF. Nevertheless, some issues that arose were
speciﬁc to certain conditions. The original text of survey
submissions and research recommendations are avail-
able in UK DUETs. Considerable reﬁnement will be
required in order to take each topic forward as a feasible
substantive project. In some cases it would be sensible to
design studies with more deﬁned subsets of this popula-
tion with particular characteristics, diagnosis or age
groups. Most of the questions encompass a range of
interventions that would not be realistic to investigate in
a single study. Therefore, a speciﬁc intervention and
comparator would need to be selected and/or a therapy
regimen carefully deﬁned. Relevant outcomes need to
be speciﬁed and decisions made about how and when
the outcomes should be measured. We advocate that
families should be consulted about these decisions, con-
sistent with the ethos of patient and public involvement.
Consistent with the ethos of the PSP, we would also want
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Table 2 Final ranking order priority of the questions, including history of rank order from the interim survey and small groups
Question considered
Interim survey Workshop first groups Second small groups
Final
rank
Family
score
Clinician
score
Charity
score
Collated
rank
K-1
rank
S-1
rank
L-1
rank
Collated
rank
K-2
rank
S-2
rank
L-2
rank Collated
Does the timing and intensity of ‘early’
intervention (eg, providing information,
physiotherapy, speech and language
therapy, occupational therapy, etc) alter
effectiveness of therapies for infants and
young children with neurodisability, including
those without specific diagnosis? What is the
appropriate age of onset/strategies/dosage/
direction of therapy interventions?
1 1 1 1 1 1 1 1 1 1 1 1 1
To improve communication for children and
young people with neurodisability: (A) what is
the best way to select the most appropriate
communication aids? and (B) how to
encourage staff/carers to use aids to enable
communication?
3 5 10= 3 2 2 5 2 2 2 2 2 2
Are strategies to improve children’s (ie,
peers) attitudes towards disability (eg, buddy
or circle of friends, etc) effective to improve
inclusion and participation within educational,
social and community settings?
10= 4 2= 4 3 4 6 3 3 3 3 3 3
Does appropriate provision of wheelchairs to
enable independent mobility for very young
children improve their self-efficacy?
22 14 22 24 5 8 2 4 4 4 4 4 4
Is counselling/psychological intervention
effective to promote the mental health of
children and young people with
neurodisability?
18 23 6= 17 4 5 14 6 6 6 6 6 5
What is the (long-term) comparative safety
and effectiveness of medical and surgical
spasticity management techniques (BoNT-A,
SDR, ITB, orally administered medicines) in
children and young people with
neurodisability?
16 8= 12 8 12 13 4 7 7 7 5 7 6
Does a structured training programme,
medicines and/or surgery speed up the
achievement of continence (either/or faecal
or urinary) for children and young people
with neurodisability?
6= 20 19= 15 16 16 7 12 8 8 9 8 7
What strategies are effective to improve
engagement in physical activity (to improve
17 7 21 14 20 6 8 9 9 9 13 9 8
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Table 2 Continued
Question considered
Interim survey Workshop first groups Second small groups
Final
rank
Family
score
Clinician
score
Charity
score
Collated
rank
K-1
rank
S-1
rank
L-1
rank
Collated
rank
K-2
rank
S-2
rank
L-2
rank Collated
fitness, reduce obesity, etc) for children and
young people with neurodisability?
Which school characteristics (eg, policies,
attitudes of staff, etc) are most effective to
promote inclusion of children and young
people with neurodisability in education and
after-school clubs?
20 10 4 7 11 3 22 10 10 13 10 10 9
What is the safety and effectiveness of
melatonin (or other drugs) compared to
behavioural strategies to manage sleep
disorders in children and young people with
neurodisability?
14 19 8 12 8 22 16 17 19 10 17 15 10
What is the safety and effectiveness of drugs
compared to cognitive behavioural therapy to
treat anxiety in children and young people
with ASDs?
25 21 2= 20 18 12 3 8 14 11 8 11 11
Are any types of physical therapy (eg,
Bobath, Neuro-Developmental Therapy,
hydro, constraint, strength-training, etc) more
or less effective to promote motor functioning
in children and young people with
neurodisability (eg, cerebral palsy, acquired
brain injury)?
2 2 5 2 7 7 9 5 5 5 7 5 12
Are sensory processing/integration
therapeutic programmes effective in
improving behaviour and/or increasing play/
participation for children and young people
with neurodisability?
8 8= 6= 5 14 21 10 16 11 18 12 12 13
Are behavioural and sensory interventions
(eg, early intensive behavioural intervention,
EarlyBird, enforced socialisation with peers,
etc) effective in managing symptoms of
ASD?
23= 17 17 21 9 15 17 13 15 12 15 13 14
Are postural management programmes
(using standing frames and sleep systems,
etc) effective and cost-effective to prevent
deformity (hip and/or spine) and improve
function in children and young people with
neurodisability? What is the incidence of
21 6 15= 13 13 14 11 11 13 15 14 14 15
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Table 2 Continued
Question considered
Interim survey Workshop first groups Second small groups
Final
rank
Family
score
Clinician
score
Charity
score
Collated
rank
K-1
rank
S-1
rank
L-1
rank
Collated
rank
K-2
rank
S-2
rank
L-2
rank Collated
adverse effects, for example, pain, sleep
problems, etc?
Are child-focused strategies (eg, one-to-one
or group social and skills training) effective to
improve confidence, self-esteem and
promote participation in recreation and
leisure activities for children and young
people with neurodisability?
19 3 14 9 10 18 13 14 16 16 16 16 16
Do cross-sector interventions (eg, key
workers, named contacts to promote
integrated health, social care, education)
improve school attendance, reduce
admissions, and parents’ satisfaction and
experience of care for children and young
people with neurodisability?
10= 11 23 16 6 19 21 18 18 14 20 17 17
Does promoting public positive attitudes
towards disability improve participation in
recreation and leisure activities for children
and young people with neurodisability?
4 16 15= 10 17 9 15 15 17 17 19 18 18
Are dietary modifications/restrictions (eg,
gluten, casein, dairy, meat, etc) effective in
managing symptoms of ASD?
5 24 13 17 19 25 12 22 22 22 11 19 19
Are oro-motor exercises effective to improve
eating and/or communication for children and
young people with neurodisability?
15 15 25 23 22 10 23 20 12 21 22 20 20
Are any designs of orthoses (eg, Lycra,
kinesiotaping, plastic, etc) more or less
effective to promote functioning and prevent
deformity for children and young people with
neurodisability?
6= 12 10= 6 23 11 18 19 20 19 18 21 21
Are interventions to improve consistency of
approach between health and education
agencies (eg, keyworkers) effective to
improve behavioural problems in children
with ASD?
13 18 9 11 15 20 20 21 21 20 21 22 22
What is the (long-term) safety and
effectiveness of drugs used in seizure
management, especially in terms of adverse
effects on learning, psychosis, anxiety, anger
and rage?
23= 22 19= 25 21 23 19 23 23 23 23 23 23
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to see beneﬁts for the widest range of disabled children,
young people and their families.
The scope of this PSP focused on interventions
(things that might be done) to improve the health and
well-being of children and young people with neurodisa-
bility. Thus, our scope excluded aspects of diagnosis,
cure and causal mechanisms. These issues were raised in
our survey and have been identiﬁed as research prior-
ities in other condition-speciﬁc initiatives, for instance
for cerebral palsy.19 Potential interventions were any
environmental factor in the ICF; while there was a pre-
dominance of medical and surgical treatments and ther-
apies, suggestions ranged across products and
technology, relationships, attitudes, and service organisa-
tions and delivery. This indicates the broad ways that par-
ticipants’ perceived health and well-being could be
inﬂuenced, outside conventional deﬁnitions of health
services. Thus, our results encourage research on social
and educational interventions alongside the research on
the effectiveness of medical interventions, and also tai-
loring and evaluating public health guidance to be
appropriate to children and young people with neurodi-
sability. This links well to the NIHR call for “research
into the evaluation of public health measures, health-
care interventions and health services to better manage
long term conditions in children and young people.”
(http://www.themedcalls.nihr.ac.uk/children).
Some uncertainties raised in our survey are clearly
important topics for research, but were considered
outside the scope of this particular initiative, as the
agreed scope was to identify interventions that would
have an impact on practice in 3–5 years. Examples
include stem cell therapies for some conditions and a
call for ways to prevent young people with neurodisabil-
ity coming into contact with the youth-offending service,
which has been recognised as an issue.20 Transition to
adult services was the top priority identiﬁed in a North
American consensus study ranking research priorities
for ‘developmental-behavioral paediatrics’.21 However,
for these topics, it was not possible for the Steering
Group to identify any speciﬁc intervention that could be
evaluated. Such research topics are often approached, in
the ﬁrst instance, as observational studies to understand
factors associated with efﬁcient processes and variation
in health outcomes22; if an intervention can be deﬁned,
then effectiveness can be evaluated using an appropriate
research design. Our scope focused on children and
young people; hence, issues raised in our survey relating
to the health and well-being of parent carers were
excluded. There is ample evidence that parent carers
are at risk of poorer physical and psychological health.23
Therefore, evaluating ways to promote their health and
well-being is vital.
We also encountered some topics that the JLA consid-
ers ‘unknown knowns’, where research has produced
potentially useful ﬁndings but people are not aware of
them. For example, several parents in the survey raised
issues related to how to assess pain in children with
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communication difﬁculties. In fact there exist several
methods to assess pain for children who cannot self-
report using structured approaches asking parents or
carers about behaviours thought to be pain-related.24 25
This exempliﬁes the recognised gap between potential
users of research ﬁndings and research outputs.
Researchers should do more to disseminate outputs to
all potential users; there is also a need to educate and
empower patients and carers to meet their information
needs.
The issues prioritised are the result of the JLA process
that involved engaging partner organisations and soci-
eties, a survey, checking uncertainties, and interim and
ﬁnal prioritisation stages. There are several limitations
that should be borne in mind when considering the
issues identiﬁed and prioritised. Some potential partners
did not respond; we failed to engage many professionals
from primary care, and few psychology and psychiatry
colleagues participated in the process. There was varying
engagement of partners over the duration of the
project. Our survey used an open question approach
that led to large number of suggestions being classiﬁed
as ‘out-of-scope’ because a PICO structured research
question could not be determined; careful consideration
should be given to using a more structured PICO format
for future surveys, although such an approach may deter
others. The participation of the NNPCF enabled families
from around England to take part in the survey and
ﬁnal workshop; nevertheless, those who took part were
probably not socioeconomically or ethnically representa-
tive of the population.
Another limitation to our survey was the small number
of ideas from children and young people in the survey.
It is recognised that their perspectives are often not
represented in research.26 We did try various methods to
engage children and young people with neurodisability
in the survey; unfortunately, our resources and time
were insufﬁcient to engage children and young people
meaningfully. The Steering Group was disappointed
with this aspect. We do believe that with adequate
resources and careful planning, children and young
people with neurodisability could play a greater role
in the identiﬁcation of potential research topics.
Box 2 Top 10 research questions agreed as shared
priorities
1. Does the timing and intensity of therapies (eg, physical,
occupational and speech and language therapy, ‘early inter-
vention’, providing information, etc) alter the effectiveness of
therapies for infants and young children with neurodisability,
including those without specific diagnosis? What is the
appropriate age of onset/strategies/dosage/direction of
therapy interventions?
2. To improve communication for children and young people
with neurodisability: (A) what is the best way to select the
most appropriate communication strategies? And (B) how to
encourage staff/carers to use these strategies to enable
communication?
3. Are child-centred strategies to improve children’s (ie, peers)
attitudes towards disability (eg, buddy or circle of friends,
etc) effective to improve inclusion and participation within
educational, social and community settings?
4. Does appropriate provision of wheelchairs to enable inde-
pendent mobility for very young children improve their
self-efficacy?
5. Are counselling/psychological strategies (eg, talking therap-
ies) effective to promote the mental health of children and
young people with neurodisability?
6. What is the (long-term) comparative safety and effectiveness
of medical and surgical spasticity management techniques
(botulinum neurotoxin A, selective dorsal rhizotomy, intra-
thecal baclofen, orally administered medicines) in children
and young people with neurodisability?
7. Does a structured training programme, medicines and/or
surgery speed up the achievement of continence (either/or
faecal or urinary) for children and young people with
neurodisability?
8. What strategies are effective to improve engagement in phys-
ical activity (to improve fitness, reduce obesity, etc) for chil-
dren and young people with neurodisability?
9. Which school characteristics (eg, policies, attitudes of staff,
etc) are most effective to promote inclusion of children and
young people with neurodisability in education and after-
school clubs?
10. What is the long-term safety, effectiveness and sustainability
of behavioural strategies and/or drugs (eg, melatonin) to
manage sleep disturbance in children and young people with
neurodisability (outcomes include time to onset, duration,
and reducing impact on family)?
Figure 1 Flow chart showing the process and numbers of
participants and research suggestions and questions at each
stage.
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For instance, such approaches were successful in captur-
ing children and young people’s views to identify key
health outcomes in neurodisability.27 The context of
health research in general and ‘treatment uncertainties’
in particular would require careful explanation; some
creative activity would help to make the engagement
accessible for young people. We would encourage collea-
gues engaging in a research priority setting to plan and
deploy adequate resources to capture the views of chil-
dren and young people, perhaps using focus groups and
interviews. On a more positive note, we were pleased
that young adults with neurodisability took part in the
ﬁnal workshop, and their preferences and views were
captured in the ranking of research priorities.
Previous JLA PSPs have focused on a speciﬁc diagnosis.
Our non-categorical approach was predicated on the basis
that many conditions under the umbrella of neurodisabil-
ity create similar difﬁculties, some children with neurodisa-
bility are not given a named diagnosis and that we wanted
the results to beneﬁt as many young people as possible.
Nevertheless, our non-categorical approach to neurodisa-
bility may have excluded some speciﬁc issues important
for particular diagnoses and/or inﬂuenced the way sugges-
tions were aggregated and research topic questions
framed. There are a large number of UK charities support-
ing families of children with conditions under the
umbrella of neurodisability28; although we approached
many of these agencies, few condition-speciﬁc organisa-
tions became partners. Hence, there remain ample oppor-
tunities for pursuing similar research PSPs for speciﬁc
neurodisability conditions or syndromes.
Clearly initiatives to fulﬁl the growing aspiration to
engage patients and carers and non-researcher clinicians
in setting the research agenda are challenging. This
project used the JLA methodology in the area of paedi-
atric neurodisability and was successful in producing a
shortlist of prioritised topics. However, a number of
lessons were learned in carrying out the work and we
highlight some of these to inform future initiatives. First,
stakeholders could have been engaged earlier to set the
scope of the project, to consider whether to focus on
existing treatments and therapies consistent with tack-
ling ‘treatment uncertainties’, or take a broader scope
to encompass other topics that epidemiological or
laboratory-based research could address. Second, identi-
fying issues would beneﬁt from face-to-face question gen-
eration where facilitators could help reﬁne emerging
topics into PICO-structured research questions. This will
be particularly pertinent when engaging with children
and young people. Third, aggregating topics is necessary
to reduce the large number of topics to a number that is
cognitively manageable for the prioritisation stages. This
dilutes the more speciﬁcally deﬁned research questions
into broad topics, which can undermine researchers’
perceptions of the utility of the ﬁnal product. We
devised methods for categorising topics as there was
little guidance from JLA for carrying out this aspect of
the process; however, these methods require further
reﬁnement. Finally, key stakeholders to facilitate the
move from prioritised topics to answering research ques-
tions are researchers and funding agencies. This could
be perceived as part of knowledge translation or
exchange cycle involving patients, carers and clinicians
asking funding agencies to commission and researchers
to carry out research to address topics about which they
need information to inform decisions.
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